Gynecological Cancer
Nedaplatin exhibited strong antitumor activity in gynecological carcinomas
Published in Cancer Weekly, February 14th, 2006
According to a study from Japan, "The tetrazolium dye (MTT) assay is useful for predicting chemosensitivity. Using the MTT assay, all in vitro chemosensitivity test was designed for nedaplatin (cis-diammine glycolato platinum; 254-S) and the results were compared with the sensitivity to cisplatin in 137 resected gynecological carcinomas."
"The mean tumor inhibition rate [I.R.;%] for nedaplatin was equal or superior to cisplatin in 15 cervical [70.7% vs. 63.9%], 65 ovarian [61.7% vs. 54.8%] and 57 endometrial carcinomas [52.1% vs. 47.7%]. In ovarian carcinomas, the I.R.s...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-02-14)
More Articles from Cancer Weekly
- Bone Tumors
FDG-PET used to detect bone tumors when bone scintigraphy gave negative findings - Breast Cancer
New breast magnetic resonance imaging technique endorsed - Colon Cancer
Use of artepillin C helps prevent colon cancer - Drug Resistance
Chromosomal alterations resulted in drug resistance in cancer cells - Prostate Cancer
Antiprostasome antibody titer used as supplemental prostate cancer marker - Abdominal Tumors
Abdominal position shifts detected with radiation-planning CT scans - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
